- Trials with a EudraCT protocol (115)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (4)
115 result(s) found for: Olanzapine.
Displaying page 1 of 6.
| EudraCT Number: 2008-005019-16 | Sponsor Protocol Number: ROCKSAN | Start Date*: 2009-03-19 |
| Sponsor Name:AMC- academisch psychiatrisch centrum | ||
| Full Title: Randomized Olanzapine Clozapine Key study on Schizophrenia and Addiction in the Netherlands (ROCKSAN) | ||
| Medical condition: A multi-centre prospective, randomized, double blind designed study examining the effectiveness and costs of clozapine compared to olanzapine in patients with schizophrenia or related psychotic dis... | ||
| Disease: | ||
| Population Age: Adults | Gender: Male, Female | |
| Trial protocol: NL (Ongoing) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2018-002267-25 | Sponsor Protocol Number: SEOTP-2018 | Start Date*: 2018-07-18 |
| Sponsor Name:Fakultní nemocnice Brno | ||
| Full Title: SAFETY AND EFFICACY OF OLANZAPINE TREATMENT IN PSYCHOSIS: EFFECT OF GENETIC AND EPIGENETIC FACTORS – COVARIATES OF TREATMENT RESPONSE | ||
| Medical condition: Psychoses | ||
| Disease: | ||
| Population Age: Adults | Gender: Male, Female | |
| Trial protocol: CZ (Completed) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2006-005346-37 | Sponsor Protocol Number: F1D-MC-HGMR | Start Date*: Information not available in EudraCT | |||||||||||
| Sponsor Name:Eli Lilly and Company Limited | |||||||||||||
| Full Title: A Randomized, Double-Blind, Placebo-Controlled Maintenance of Effect Study of Olanzapine in the Treatment of Disruptive Behavioral Symptoms in Children and Adolescents with Pervasive Developmental ... | |||||||||||||
| Medical condition: children and adolescents with disruptive behavioral symptoms associated with Pervasive Developmental Disorders (PDD) | |||||||||||||
|
|||||||||||||
| Population Age: Children, Adolescents, Under 18 | Gender: Male, Female | ||||||||||||
| Trial protocol: NL (Ongoing) | |||||||||||||
| Trial results: (No results available) | |||||||||||||
| EudraCT Number: 2004-002147-27 | Sponsor Protocol Number: | Start Date*: 2005-05-26 |
| Sponsor Name:Department of General Psychiatry | ||
| Full Title: Influence of treatment of olanzapine and ziprasidone on transcapillary glucose transport in human skeletal muscle | ||
| Medical condition: Healthy volunteers | ||
| Disease: | ||
| Population Age: Adults | Gender: Male | |
| Trial protocol: AT (Completed) | ||
| Trial results: View results | ||
| EudraCT Number: 2004-000986-37 | Sponsor Protocol Number: F1D-MC-HGKB | Start Date*: 2004-11-26 |
| Sponsor Name:Eli Lilly and Company Limited | ||
| Full Title: An Open-Label Study of Intramuscular Olanzapine Depot in Patients With Schizophrenia or Schizoaffective Disorder | ||
| Medical condition: Schizophrenia or Schizoaffective Disorder | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male, Female | |
| Trial protocol: SK (Completed) CZ (Completed) ES (Completed) SE (Completed) BE (Completed) IT (Completed) | ||
| Trial results: View results | ||
| EudraCT Number: 2004-001041-15 | Sponsor Protocol Number: N3D/FOR-OCA-06 | Start Date*: 2004-07-26 |
| Sponsor Name:Neuro3d | ||
| Full Title: MULTICENTRE, DOUBLE-BLIND, RISING DOSE PARALLEL GROUP STUDY OF THE EFFICACY AND TOLERABILITY OF OCAPERIDONE VERSUS OLANZAPINE IN SCHIZOPHRENIC PATIENTS | ||
| Medical condition: The populations of the study will be: -schizophrenic patients according to DSM IV-TR diagnosis -have to present the first symptoms of the schizophrenia for at least one year -have to present an exa... | ||
| Disease: | ||
| Population Age: Adults | Gender: Male, Female | |
| Trial protocol: LV (Completed) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2004-001482-17 | Sponsor Protocol Number: F1D-MC-HGKQ(b) | Start Date*: 2004-10-15 |
| Sponsor Name:Eli Lilly and Company | ||
| Full Title: Olanzapine Versus Divalproex and Placebo in the Treatment of Mild to Moderate Mania Associated with Bipolar I disorder. | ||
| Medical condition: Manic or Mixed Episodes Associated with Bipolar I Disorder | ||
| Disease: | ||
| Population Age: Adults | Gender: Male, Female | |
| Trial protocol: LT (Completed) | ||
| Trial results: View results | ||
| EudraCT Number: 2006-001661-41 | Sponsor Protocol Number: Ser01 | Start Date*: 2006-06-08 |
| Sponsor Name:Karolinska University Hospital | ||
| Full Title: Body Composition and Metabolic Changes During Antipsychotic Treatment. A Randomized Trial Comparing Sertindole and Olanzapine. | ||
| Medical condition: Patients with schizophrenia diagnosis (DSM-IV) | ||
| Disease: | ||
| Population Age: Adults | Gender: Male, Female | |
| Trial protocol: SE (Prematurely Ended) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2007-000512-82 | Sponsor Protocol Number: OLA-D | Start Date*: 2007-06-12 |
| Sponsor Name:Charité Universitätsmedizin Berlin | ||
| Full Title: Optimal Duration of Olazapine Add-on therapy in Major Depression: A double-blind, placebo-controlled, randomized, Phase III, Pilot Study in parallel group Design | ||
| Medical condition: Major Depression | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male, Female | |
| Trial protocol: DE (Completed) | ||
| Trial results: View results | ||
| EudraCT Number: 2004-000589-11 | Sponsor Protocol Number: F1D-MC-HGKR | Start Date*: 2004-08-10 |
| Sponsor Name:ELI LILLY and COMPANY | ||
| Full Title: Protocol F1D-MC-HGKR. Olanzapine Plus Carbamazepine Versus Carbamazepine Alone in the Treatment of Manic or Mixed Episodes Associated with Bipolar I Disorder | ||
| Medical condition: Manic or Mixed Episodes Associated with Bipolar I Disorder | ||
| Disease: | ||
| Population Age: Adults | Gender: Male, Female | |
| Trial protocol: HU (Completed) | ||
| Trial results: View results | ||
| EudraCT Number: 2009-013403-55 | Sponsor Protocol Number: NL2861002909 | Start Date*: 2009-10-07 |
| Sponsor Name:VU university medical center | ||
| Full Title: Early recognition and optimal treatment of delirium in patients with advanced cancer. | ||
| Medical condition: Delirium in patients with advanced cancer | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male, Female | |
| Trial protocol: NL (Ongoing) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2005-004391-21 | Sponsor Protocol Number: A1281147 | Start Date*: 2006-06-23 | |||||||||||
| Sponsor Name:Pfizer S.A. | |||||||||||||
| Full Title: A MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PARALLEL GROUP STUDY, COMPARING THE EFFICACY AND TOLERABILITY OF ZIPRASIDONE (ZELDOX®, GEODON®) VS OLANZAPINE (ZYPREXA®) IN THE TREATMENT AND MAINTENANCE OF... | |||||||||||||
| Medical condition: Bipolar I Disorder | |||||||||||||
|
|||||||||||||
| Population Age: Adults | Gender: Male, Female | ||||||||||||
| Trial protocol: ES (Completed) GR (Prematurely Ended) DE (Completed) FR (Completed) IT (Prematurely Ended) | |||||||||||||
| Trial results: View results | |||||||||||||
| EudraCT Number: 2014-003834-21 | Sponsor Protocol Number: 80-83600-98-10086 | Start Date*: 2016-09-23 |
| Sponsor Name:Erasmus Medical Center Rotterdam | ||
| Full Title: Effectiveness of penfluridol (oral long acting neuroleptic) as compared to second generation oral neuroleptics in psychotic disorder patients: an open label randomized controlled trial. | ||
| Medical condition: Psychotic disorders | ||
| Disease: | ||
| Population Age: Adults | Gender: Male, Female | |
| Trial protocol: NL (Prematurely Ended) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2021-003588-85 | Sponsor Protocol Number: PSYCHIC | Start Date*: 2022-01-11 |
| Sponsor Name:UCLouvain | ||
| Full Title: Individualized care with antipsychotics in patients suffering from schizophrenia spectrum disorders- How to conciliate plasma concentrations, clinical response and genetic factors ? | ||
| Medical condition: Schizophrenia, schizoaffective disorders, psychosis not otherwise specified, and dellusional disorders | ||
| Disease: | ||
| Population Age: Adults | Gender: Male, Female | |
| Trial protocol: BE (Completed) | ||
| Trial results: View results | ||
| EudraCT Number: 2004-001308-11 | Sponsor Protocol Number: F1D-XM-HGLW | Start Date*: 2004-08-19 | |||||||||||
| Sponsor Name:Lilly.S.A. | |||||||||||||
| Full Title: Optimal Treatment Duration with Olanzapine following Remission of Manic or Mixed Episode. An Open-Label, Randomized Trial Comparing Two Treatment Strategies | |||||||||||||
| Medical condition: to compare the efficacy in the prevention of relapse to manic, depressive, or mixed episodes in two groups of bipolar I patients | |||||||||||||
|
|||||||||||||
| Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
| Trial protocol: ES (Ongoing) | |||||||||||||
| Trial results: (No results available) | |||||||||||||
| EudraCT Number: 2017-000497-11 | Sponsor Protocol Number: ALK3831-A307 | Start Date*: 2017-07-13 | |||||||||||||||||||||
| Sponsor Name:Alkermes Inc | |||||||||||||||||||||||
| Full Title: A Study to Evaluate the Effect of ALKS 3831 Compared to Olanzapine on Body Weight in Young Adults with Schizophrenia, Schizophreniform, or Bipolar I Disorder Who are Early in Their Illness | |||||||||||||||||||||||
| Medical condition: Schizophrenia, schizophreniform disorder or bipolar I disorder | |||||||||||||||||||||||
|
|||||||||||||||||||||||
| Population Age: Adults | Gender: Male, Female | ||||||||||||||||||||||
| Trial protocol: AT (Completed) DE (Completed) ES (Ongoing) IT (Completed) RO (Ongoing) | |||||||||||||||||||||||
| Trial results: View results | |||||||||||||||||||||||
| EudraCT Number: 2005-004157-99 | Sponsor Protocol Number: F1D-MC-HGLQ | Start Date*: 2006-02-16 |
| Sponsor Name:Lilly S.A. | ||
| Full Title: Estudio aleatorizado, abierto en el que se comparan los efectos del pamoato de olanzapina depot con los de olanzapina oral en los resultados del tratamiento en pacientes ambulatorios con esquizofrenia | ||
| Medical condition: Esquizofrenia | ||
| Disease: | ||
| Population Age: Adults | Gender: Male, Female | |
| Trial protocol: ES (Completed) PT (Completed) SK (Completed) | ||
| Trial results: View results | ||
| EudraCT Number: 2007-003342-15 | Sponsor Protocol Number: F1D-MC-HGMT | Start Date*: 2007-12-05 |
| Sponsor Name:Eli Lilly and Company Limited | ||
| Full Title: A Randomized, Open-Label Study Comparing the Effectiveness of Olanzapine Pamoate Depot with Haloperidol Decanoate in the Treatment of Schizophrenia | ||
| Medical condition: Schizophrenia | ||
| Disease: | ||
| Population Age: Adults | Gender: Male, Female | |
| Trial protocol: HU (Prematurely Ended) FR (Completed) GB (Prematurely Ended) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2015-002294-38 | Sponsor Protocol Number: DANSAC-open | Start Date*: 2015-08-31 | |||||||||||
| Sponsor Name:Odense University Hospital | |||||||||||||
| Full Title: DANSAC-open: A multicenter, open label study to investigate the efficacy and tolerability of olanzapine in patients with advanced cancer not receiving chemotherapy or irradiation. | |||||||||||||
| Medical condition: Nausea and/or vomiting | |||||||||||||
|
|||||||||||||
| Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
| Trial protocol: DK (Completed) | |||||||||||||
| Trial results: View results | |||||||||||||
| EudraCT Number: 2007-001520-12 | Sponsor Protocol Number: D1443C00013 | Start Date*: 2008-01-11 |
| Sponsor Name:Unidade de Investigação em Saúde Mental e Psiquiatria do Centro Hospitalar Conde de Ferreira | ||
| Full Title: Efficacy and distinctive effects of atypical antipsychotics on cognitive symptoms in dual diagnosis – A phase IIIb, randomized, open-labelled study to evaluate the cognitive effects of quetiapine X... | ||
| Medical condition: Patients with both schizophrenia and substance abuse disorder | ||
| Disease: | ||
| Population Age: Adults | Gender: Male | |
| Trial protocol: PT (Prematurely Ended) | ||
| Trial results: (No results available) | ||
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
| Download Options: | |
|---|---|
| Number of Trials to download: | |
| Download Content: | |
| Download Format: | |
| Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. | |
Query did not match any studies.
